Mga Batayang Estadistika
| LEI | 549300Z17PKDH79BWD30 |
| CIK | 1757143 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Aesthetic Medical International Holdings Group Limited - Depositary Receipt (Common Stock)
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| August 19, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2025 Commission File Number: 001-39088 Aesthetic Medical International Holdings Group Limited 1122 Nanshan Boulevard Nanshan District, Shenzhen Guangdong Province, China 518052 (Address |
|
| April 25, 2025 |
Exhibit 13.1 Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of Aesthetic Medical International Holdings Group Limited (the “Company”) on Form 20-F for the year ended December 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Zhang Chen, Chairman of the |
|
| April 25, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SEC |
|
| April 25, 2025 |
Exhibit 12.1 Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Zhang Chen, certify that: 1. I have reviewed this annual report on Form 20-F of Aesthetic Medical International Holdings Group Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to |
|
| April 25, 2025 |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Exhibit 15.2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in the Registration Statement of Aesthetic Medical International Holdings Group Limited on Form F-3 (File No. 333-265667) of our report dated April 25, 2025, , with respect to the consolidated balance sheets of Aesthetic Medical International Holdings Group Limited as of December 31, |
|
| April 25, 2025 |
Exhibit 13.2 Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of Aesthetic Medical International Holdings Group Limited (the “Company”) on Form 20-F for the year ended December 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Wu Guanhua, Chief Financial |
|
| April 25, 2025 |
Exhibit 12.2 Certification by the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Wu Guanhua, certify that: 1. I have reviewed this annual report on Form 20-F of Aesthetic Medical International Holdings Group Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to |
|
| April 25, 2025 |
Exhibit 15.1 Date: April 25, 2025 Aesthetic Medical International Holdings Group Limited 1122 Nanshan Boulevard, Nanshan District, Shenzhen, Guangdong Province, China 518052 Dear Sirs/Madams, We hereby consent to the reference to our firm in Aesthetic Medical International Holdings Group Limited’s annual report on Form 20-F for the fiscal year ended December 31, 2024, which will be filed by Aesthe |
|
| January 6, 2025 |
Aesthetic Medical International Holdings Group Ltd Aesthetic Medical International Holdings Group Ltd January 6, 2025 VIA EDGAR Mr. Conlon Danberg Ms. Margaret Sawicki Division of Corporation Finance Office of Industrial Applications and Services U.S. Securities and Exchange Commission 100 F Street, N.E. Mail Stop 4631 Washington, DC 20549 Re: Aesthetic Medical International Holdings Group Ltd Form 20-F for the Year Ended December 31, 2023 Filed A |
|
| December 20, 2024 |
Aesthetic Medical International Holdings Group Ltd Aesthetic Medical International Holdings Group Ltd December 20, 2024 VIA EDGAR Mr. |
|
| December 13, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 3)* Aesthetic Medical International Holdings Group Limited (Name of Issuer) Ordinary shares, par value $0.001 per share (Title of Class of Securities) 00809M104** (CUSIP Number) Australia Wanda International Company Limited 19/F, No.3 Lockhart Road Wanchai |
|
| December 13, 2024 |
Exhibit H Joint Filing Agreement The undersigned acknowledge and agree that the foregoing statement on Schedule 13D/A is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13D/A shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing statements. |
|
| November 18, 2024 |
Aesthetic Medical International Holdings Group Ltd Aesthetic Medical International Holdings Group Ltd November 18, 2024 VIA EDGAR Mr. |
|
| October 31, 2024 |
Aesthetic Medical International Announces Change of Director Exhibit 99.1 Aesthetic Medical International Announces Change of Director Shenzhen, China, October 31, 2024 — Aesthetic Medical International Holdings Group Limited (OTCQX: PAIYY) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, announced (1) the resignation of Ms. Xu Tianqing from her position as an independent director and a member of the audit committee of th |
|
| October 31, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2024 Commission File Number: 001-39088 Aesthetic Medical International Holdings Group Limited 1122 Nanshan Boulevard Nanshan District, Shenzhen Guangdong Province, China 518052 (Address |
|
| October 23, 2024 |
Aesthetic Medical International Holdings Group Ltd Aesthetic Medical International Holdings Group Ltd October 23, 2024 VIA EDGAR Mr. Conlon Danberg Ms. Margaret Sawicki Division of Corporation Finance Office of Industrial Applications and Services U.S. Securities and Exchange Commission 100 F Street, N.E. Mail Stop 4631 Washington, DC 20549 Re: Aesthetic Medical International Holdings Group Ltd Form 20-F for the Year Ended December 31, 2023 Filed |
|
| October 8, 2024 |
Aesthetic Medical International Holdings Group Ltd Aesthetic Medical International Holdings Group Ltd October 8, 2024 VIA EDGAR Mr. Conlon Danberg Ms. Margaret Sawicki Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services 100 F Street, N.E. Mail Stop 4631 Washington, DC 20549 Re: Aesthetic Medical International Holdings Group Ltd Form 20-F for Fiscal Year Ended December 31, 2023 Filed Apr |
|
| September 19, 2024 |
Aesthetic Medical International Holdings Group Ltd Aesthetic Medical International Holdings Group Ltd September 19, 2024 VIA EDGAR Mr. |
|
| August 27, 2024 |
Aesthetic Medical International Holdings Group Ltd Aesthetic Medical International Holdings Group Ltd August 27, 2024 VIA EDGAR Mr. Conlon Danberg Ms. Margaret Sawicki Division of Corporation Finance Office of Industrial Applications and Services U.S. Securities and Exchange Commission 100 F Street, N.E. Mail Stop 4631 Washington, DC 20549 Re: Aesthetic Medical International Holdings Group Ltd Form 20-F for the Year Ended December 31, 2023 Filed A |
|
| August 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2024 Commission File Number: 001-39088 Aesthetic Medical International Holdings Group Limited 1122 Nanshan Boulevard Nanshan District, Shenzhen Guangdong Province, China 518052 (Address |
|
| July 10, 2024 |
Aesthetic Medical International Holdings Group Ltd. Announces the Commencement of OTCQX Trading Exhibit 99.1 Aesthetic Medical International Holdings Group Ltd. Announces the Commencement of OTCQX Trading Shenzhen, China, July 10, 2024 (GLOBE NEWSWIRE) — Aesthetic Medical International Holdings Group Limited (OTCQX: PAIYY) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, is pleased to announce that its American Depositary Shares (the “ADSs”) are now tradin |
|
| July 10, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2024 Commission File Number: 001-39088 Aesthetic Medical International Holdings Group Limited 1122 Nanshan Boulevard Nanshan District, Shenzhen Guangdong Province, China 518052 (Address of |
|
| May 20, 2024 |
Exhibit 99.1 Aesthetic Medical International Holdings Group Ltd. Announces Receipt of Delisting Decision from the Nasdaq Hearings Panel Shenzhen, China, May 20, 2024 (GLOBE NEWSWIRE) — Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, today announced that it has received a determination letter o |
|
| May 20, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024 Commission File Number: 001-39088 Aesthetic Medical International Holdings Group Limited 1122 Nanshan Boulevard Nanshan District, Shenzhen Guangdong Province, China 518052 (Address of |
|
| April 25, 2024 |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Exhibit 16.1 April 25, 2024 Securities and Exchange Commission 100F Street, N.E. Washington, DC 20549 Ladies and Gentlemen: We have read Item 16F of Form 20-F dated April 25, 2024, of Aesthetic Medical International Holdings Group Ltd. and are in agreement with statements contained in the first to fourth paragraphs with reference to us therein. We have no basis to agree or disagree with other stat |
|
| April 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SEC |
|
| April 25, 2024 |
Exhibit 13.2 Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of Aesthetic Medical International Holdings Group Limited (the “Company”) on Form 20-F/A for the year ended December 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Wu Guanhua, Chief Financia |
|
| April 25, 2024 |
Exhibit 13.1 Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of Aesthetic Medical International Holdings Group Limited (the “Company”) on Form 20-F/A for the year ended December 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Zhang Chen, Chairman of th |
|
| April 25, 2024 |
Exhibit 12.2 Certification by the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Wu Guanhua, certify that: 1. I have reviewed this annual report on Form 20-F of Aesthetic Medical International Holdings Group Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to |
|
| April 25, 2024 |
Exhibit 97.1 AESTHETIC MEDICAL INTERNATIONAL HOLDINGS GROUP LTD POLICY FOR THE RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION A. OVERVIEW In accordance with the applicable rules of The Nasdaq Stock Market (the “Nasdaq Rules”), Section 10D and Rule 10D-1 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (“Rule 10D-1”), the Board of Directors (the “Board”) of Aesthetic Medical In |
|
| April 25, 2024 |
Exhibit 12.1 Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Zhang Chen, certify that: 1. I have reviewed this annual report on Form 20-F of Aesthetic Medical International Holdings Group Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to |
|
| April 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 Commission File Number: 001-39088 Aesthetic Medical International Holdings Group Limited 1122 Nanshan Boulevard Nanshan District, Shenzhen Guangdong Province, China 518052 (Address o |
|
| April 25, 2024 |
Exhibit 15.1 Date: April 25, 2024 Aesthetic Medical International Holdings Group Limited 1122 Nanshan Boulevard, Nanshan District, Shenzhen, Guangdong Province, China 518052 Dear Sirs/Madams, We hereby consent to the reference to our firm in Aesthetic Medical International Holdings Group Limited’s annual report on Form 20-F for the fiscal year ended December 31, 2023, which will be filed by Aesthe |
|
| April 25, 2024 |
Exhibit 99.1 Aesthetic Medical International Holdings Group Ltd. Announces Receipt of Decision from the Nasdaq Hearings Panel for Conditional Continued Listing Shenzhen, China, April 25, 2024 (GLOBE NEWSWIRE) — Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, today announced that it has receive |
|
| March 8, 2024 |
Exhibit 99.1 Aesthetic Medical International Holdings Group Ltd. Announces Receipt of a Letter of Expected Delisting Determination From Nasdaq Staff and Intention to Request a Hearing before the Nasdaq Hearings Panel Shenzhen, China, March 8, 2024 (GLOBE NEWSWIRE) — Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medica |
|
| March 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024 Commission File Number: 001-39088 Aesthetic Medical International Holdings Group Limited 1122 Nanshan Boulevard Nanshan District, Shenzhen Guangdong Province, China 518052 (Address o |
|
| December 13, 2023 |
Aesthetic Medical International Announces Change of Auditor and Change of Director Exhibit 99.1 Aesthetic Medical International Announces Change of Auditor and Change of Director Shenzhen, China, December 12, 2023 (GLOBE NEWSWIRE) — Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, announced (1) the appointment of Onestop Assurance PAC as the Company’s independent registered p |
|
| December 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2023 Commission File Number: 001-39088 Aesthetic Medical International Holdings Group Limited 1122 Nanshan Boulevard Nanshan District, Shenzhen Guangdong Province, China 518052 (Addres |
|
| September 22, 2023 |
LIST OF CONSOLIDATED FOREIGN OPERATING ENTITIES OF THE REGISTRANT Exhibit 15.4 LIST OF CONSOLIDATED FOREIGN OPERATING ENTITIES OF THE REGISTRANT Subsidiaries Place of Incorporation Dragon Jade Holdings Limited BVI Stargaze Wealth Limited BVI Newa Medical Aesthetics Limited Hong Kong Peng Oi Investment (Hong Kong) Holdings Limited Hong Kong Shengli Aesthetic Technology Investment (Hong Kong) Company Limited Hong Kong Beijing Aomei Yixin Investment Consultant Co., |
|
| September 22, 2023 |
Exhibit 13.1 Certification by the Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of Aesthetic Medical International Holdings Group Limited (the “Company”) on Form 20-F/A for the year ended December 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Zhang Chen, Chairman of the Co |
|
| September 22, 2023 |
Exhibit 12.2 Certification by the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Wu Guanhua, certify that: 1. I have reviewed this annual report on Form 20-F/A of Aesthetic Medical International Holdings Group Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to ma |
|
| September 22, 2023 |
Exhibit 13.2 Certification by the Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of Aesthetic Medical International Holdings Group Limited (the “Company”) on Form 20-F/A for the year ended December 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Wu Guanhua, Chief Financial Of |
|
| September 22, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F/A ¨ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT |
|
| September 22, 2023 |
Exhibit 12.1 Certification by the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Zhang Chen, certify that: 1. I have reviewed this annual report on Form 20-F/A of Aesthetic Medical International Holdings Group Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to ma |
|
| September 22, 2023 |
Supplemental Submission Pursuant to Item 16I(a) of Form 20-F Exhibit 15.3 Supplemental Submission Pursuant to Item 16I(a) of Form 20-F On June 14, 2022, the Company was conclusively identified by the U.S. Securities and Exchange Commission (the “SEC”) as a Commission-Identified Issuer pursuant to the HFCAA because it filed an annual report on Form 20-F for the year ended December 31, 2021 with the SEC on May 16, 2022 with an audit report issued by Union Pow |
|
| September 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2023 Commission File Number: 001-39088 Aesthetic Medical International Holdings Group Limited 1122 Nanshan Boulevard Nanshan District, Shenzhen Guangdong Province, China 518052 (Addre |
|
| September 8, 2023 |
Exhibit 99.1 Aesthetic Medical International Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency Shenzhen, China, September 8, 2023 (GLOBE NEWSWIRE) — Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, announced that it has received a notification letter (the “N |
|
| September 5, 2023 |
Aesthetic Medical International Holdings Group Ltd Aesthetic Medical International Holdings Group Ltd September 5, 2023 VIA EDGAR Mr. |
|
| September 5, 2023 |
Aesthetic Medical International Reports First Half of 2023 Unaudited Financial Results Exhibit 99.1 Aesthetic Medical International Reports First Half of 2023 Unaudited Financial Results Shenzhen, China, September 5, 2023 (GLOBE NEWSWIRE) — Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, announced its unaudited financial results for the six months ended June 30, 2023. Mr. ZHANG |
|
| September 5, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2023 Commission File Number: 001-39088 Aesthetic Medical International Holdings Group Limited 1122 Nanshan Boulevard Nanshan District, Shenzhen Guangdong Province, China 518052 (Addre |
|
| August 17, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A (Amendment No. 2) Under the Securities Exchange Act of 1934 Aesthetic Medical International Holdings Group Limited (Name of Issuer) Ordinary shares, par value US$ 0.001 per share (Title of Class of Securities) 00809M104* (CUSIP Number) Ning Liu, Esq. King & Wood Mallesons 50th Floor, 500 Fifth Avenue New York, N |
|
| August 17, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 2)* Aesthetic Medical International Holdings Group Limited (Name of Issuer) Ordinary shares, par value $0.001 per share (Title of Class of Securities) 00809M104** (CUSIP Number) Vistra (Cayman) Limited P. O. Box 31119 Grand Pavilion, Hibiscus Way 802 West |
|
| August 17, 2023 |
Exhibit 99.1 Aesthetic Medical International Announces (i) Closing of Share Transfer, Issue of Conversion Shares, and Issue of Warrants, (ii) Resignations and Appointment of Directors, (iii) Release of Share Pledge, and (iv) Entry into certain Contractual Arrangements with respect to Equity Interests Closing of Share Transfer, Issue of Conversion Shares, and Issue of Warrants Reference is made to |
|
| August 17, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2023 Commission File Number: 001-39088 Aesthetic Medical International Holdings Group Limited 1122 Nanshan Boulevard Nanshan District, Shenzhen Guangdong Province, China 518052 (Address |
|
| August 3, 2023 |
Aesthetic Medical International Holdings Group Ltd Aesthetic Medical International Holdings Group Ltd August 3, 2023 VIA EDGAR Mr. Kyle Wiley Ms. Jennifer Thompson Division of Corporation Finance Office of Trade & Services U.S. Securities and Exchange Commission 100 F Street, N.E. Mail Stop 4631 Washington, DC 20549 Re: Aesthetic Medical International Holdings Group Ltd Form 20-F for the Year Ended December 31, 2022 Filed April 21, 2023 File No. 0 |
|
| May 23, 2023 |
Aesthetic Medical International Holdings Group Limited 1122 Nanshan Boulevard, Nanshan District, Shenzhen, Guangdong Province 518052 The People’s Republic of China May 23, 2023 VIA EDGAR Division of Corporation Finance Securities and Exchange Commission 100 F Street NE Washington, D. |
|
| May 17, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2023 Commission File Number: 001-39088 Aesthetic Medical International Holdings Group Limited 1122 Nanshan Boulevard Nanshan District, Shenzhen Guangdong Province, China 518052 (Address of |
|
| May 17, 2023 |
Aesthetic Medical International Reports First Quarter 2023 Unaudited Financial Results Exhibit 99.1 Aesthetic Medical International Reports First Quarter 2023 Unaudited Financial Results Shenzhen, China, May 17, 2023 (GLOBE NEWSWIRE) — Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, announced its unaudited financial results for the three months ended March 31, 2023. Dr. Pengwu Z |
|
| April 21, 2023 |
Exhibit 12.1 Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Zhou Pengwu, certify that: 1.I have reviewed this annual report on Form 20-F of Aesthetic Medical International Holdings Group Limited; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to m |
|
| April 21, 2023 |
Exhibit 12.2 Certification by the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Wu Guanhua, certify that: 1. I have reviewed this annual report on Form 20-F of Aesthetic Medical International Holdings Group Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to |
|
| April 21, 2023 |
Aesthetic Medical International Holdings Group Limited (the “Company”) Exhibit 1.1 Aesthetic Medical International Holdings Group Limited (the “Company”) CERTIFIED EXTRACT OF THE MINUTES OF THE ANNUAL GENERAL MEETING (THE “ANNUAL GENERAL MEETING”) OF THE COMPANY PASSED ON THE 8TH DAY OF SEPTEMBER 2022 IN ACCORDANCE WITH THE COMPANY'S ARTICLES OF ASSOCIATION “SPECIAL RESOLUTION PROPOSAL NO. 6 ARTICLES AMENDMENTS PROPOSAL NOTED THAT the Company proposes as a special re |
|
| April 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SEC |
|
| April 21, 2023 |
Exhibit 13.2 Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of Aesthetic Medical International Holdings Group Limited (the “Company”) on Form 20-F for the year ended December 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Wu Guanhua, Chief Financial |
|
| April 21, 2023 |
Exhibit 15.1 Date: April 21, 2023 Aesthetic Medical International Holdings Group Limited 1122 Nanshan Boulevard, Nanshan District, Shenzhen, Guangdong Province, China 518052 Dear Sirs/Madams, We hereby consent to the reference to our firm in Aesthetic Medical International Holdings Group Limited’s annual report on Form 20-F for the fiscal year ended December 31, 2022, which will be filed by Aesthe |
|
| April 21, 2023 |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Exhibit 15.2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-237835) of Aesthetic Medical International Holdings Group Limited of our report dated April 21, 2023 relating to the consolidated financial statements of Aesthetic Medical International Holdings Group Limited, which appears in |
|
| April 21, 2023 |
Exhibit 13.1 Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of Aesthetic Medical International Holdings Group Limited (the “Company”) on Form 20-F for the year ended December 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Zhou Pengwu, Chief Executive |
|
| February 24, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 1) Aesthetic Medical International Holdings Group Limited (Name of Issuer) Ordinary shares, par value US$ 0.001 per share (Title of Class of Securities) 00809M104* (CUSIP Number) Ning Liu, Esq. King & Wood Mallesons 50th Floor, 500 Fifth Avenue New York, N |
|
| February 16, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2023 Commission File Number: 001-39088 Aesthetic Medical International Holdings Group Limited 1122 Nanshan Boulevard Nanshan District, Shenzhen Guangdong Province, China 518052 (Addres |
|
| January 19, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2023 Commission File Number: 001-39088 Aesthetic Medical International Holdings Group Limited 1122 Nanshan Boulevard Nanshan District, Shenzhen Guangdong Province, China 518052 (Address |
|
| December 6, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2022 Commission File Number: 001-39088 Aesthetic Medical International Holdings Group Limited 1122 Nanshan Boulevard Nanshan District, Shenzhen Guangdong Province, China 518052 (Addres |
|
| December 6, 2022 |
Exhibit 99.1 Aesthetic Medical International Holdings Group Ltd. Received a Letter of Expected Delisting Determination From Nasdaq Staff and Requested a Hearing before the Nasdaq Hearings Panel SHENZHEN, China, December 6, 2022 (GLOBE NEWSWIRE) ? Aesthetic Medical International Holdings Group imitedLimited (Nasdaq: AIH) (the ?Company? or ?AIH?), a leading provider of aesthetic medical services in |
|
| November 29, 2022 |
Aesthetic Medical International Reports Third Quarter 2022 Unaudited Financial Results Exhibit 99.1 Aesthetic Medical International Reports Third Quarter 2022 Unaudited Financial Results Shenzhen, China, November 29, 2022 (GLOBE NEWSWIRE) — Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, announced its unaudited financial results for the three months ended September 30, 2022. Dr. |
|
| November 29, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2022 Commission File Number: 001-39088 Aesthetic Medical International Holdings Group Limited 1122 Nanshan Boulevard Nanshan District, Shenzhen Guangdong Province, China 518052 (Addres |
|
| September 8, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2022 Commission File Number: 001-39088 Aesthetic Medical International Holdings Group Limited 1122 Nanshan Boulevard Nanshan District, Shenzhen Guangdong Province, China 518052 (Addre |
|
| August 17, 2022 |
Aesthetic Medical International Reports First Half of 2022 Unaudited Financial Results Exhibit 99.1 Aesthetic Medical International Reports First Half of 2022 Unaudited Financial Results Shenzhen, China, August 17, 2022 (GLOBE NEWSWIRE) ? Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the ?Company? or ?AIH?), a leading provider of aesthetic medical services in China, announced its unaudited financial results for the first half ended June 30, 2022. Dr. Zhou Pen |
|
| August 17, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2022 Commission File Number: 001-39088 Aesthetic Medical International Holdings Group Limited 1122 Nanshan Boulevard Nanshan District, Shenzhen Guangdong Province, China 518052 (Address |
|
| August 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2022 Commission File Number: 001-39088 Aesthetic Medical International Holdings Group Limited 1122 Nanshan Boulevard Nanshan District, Shenzhen Guangdong Province, China 518052 (Address of |
|
| August 2, 2022 |
Exhibit 99.1 Aesthetic Medical International Holdings Group Limited 1122 Nanshan Boulevard Nanshan District, Shenzhen Guangdong Province, China 518052 NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS To be held on September 8, 2022 (or any adjournment thereof) August 2, 2022 To the Shareholders of Aesthetic Medical International Holdings Group Limited Notice is hereby given that the annual general |
|
| July 29, 2022 |
Exhibit?D ? VOTING SUPPORT AGREEMENT ? This VOTING SUPPORT AGREEMENT (this ?Agreement?), dated as of July?20, 2022 (this ?Agreement?), by and among Dr. |
|
| July 29, 2022 |
Exhibit A JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree that only one statement containing the information required by Schedule 13D and any further amendments thereto needs to be filed with respect to the beneficial ownership by each of the undersigned of the ordinary shares of Aesthetic Medical International Holdings Group Limited, a Cayman Islands company, and further agree that this Joint Filing Agreement be included as an exhibit to the Schedule 13D. |
|
| July 29, 2022 |
Exhibit D VOTING SUPPORT AGREEMENT This VOTING SUPPORT AGREEMENT (this ?Agreement?), dated as of July 20, 2022 (this ?Agreement?), by and among Dr. |
|
| July 29, 2022 |
AIH / Aesthetic Medical International Holdings Group Ltd. / Zhou Pengwu - SC 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D* Under the Securities Exchange Act of 1934 Aesthetic Medical International Holdings Group Limited (Name of Issuer) Ordinary shares, par value US$ 0.001 per share (Title of Class of Securities) 00809M104** (CUSIP Number) Dr. Zhou Pengwu 1122 Nanshan Boulevard, Nanshan District, Shenzhen, Guangdong Province, China 5 |
|
| July 29, 2022 |
Exhibit E COOPERATION AGREEMENT This COOPERATION AGREEMENT (this ?Agreement?), dated as of , 2022 (this ?Agreement?), by and among Peak Asia Investment Holdings V Limited, a company incorporated under the laws of the British Virgin Islands (?ADV?), Beacon Technology Investment Holdings Limited, a company incorporated under the laws of Hong Kong (?Beacon?), Hainan Oriental Jiechuang Investment Part |
|
| July 29, 2022 |
Exhibit C Australia Wanda International Company Limited AND Aesthetic Medical International Holdings Group Limited AND Seefar Global Holdings Limited Jubilee Set Investments Limited Pengai Hospital Management Corporation Zhou Pengwu Ding Wenting relating to SHARE PURCHASE AGREEMENT , 2022 TABLE OF CONTENTS Page Ariticles I Definitions and Interpretation 5 Section 1. |
|
| July 29, 2022 |
Exhibit E CO-SALE AGREEMENT THIS CO-SALE AGREEMENT (this ?Agreement?) is being executed and delivered as a deed on July 20, 2022, by and among: 1. |
|
| July 29, 2022 |
Exhibit G CO-SALE AGREEMENT THIS CO-SALE AGREEMENT (this ?Agreement?) is being executed and delivered as a deed on July 20, 2022, by and among: 1. |
|
| July 29, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D* Under the Securities Exchange Act of 1934 Aesthetic Medical International Holdings Group Limited (Name of Issuer) Ordinary shares, par value US$ 0.001 per share (Title of Class of Securities) 00809M104** (CUSIP Number) Ding Wenting 1122 Nanshan Boulevard, Nanshan District, Shenzhen, Guangdong Province, China 5180 |
|
| July 29, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D* Under the Securities Exchange Act of 1934 Aesthetic Medical International Holdings Group Limited (Name of Issuer) Ordinary shares, par value US$ 0.001 per share (Title of Class of Securities) 00809M104** (CUSIP Number) Ning Liu, Esq. King & Wood Mallesons 50th Floor, 500 Fifth Avenue New York, NY 10110 United Sta |
|
| July 29, 2022 |
Exhibit F VOTING SUPPORT AGREEMENT This VOTING SUPPORT AGREEMENT (this ?Agreement?), dated as of July 20, 2022 (this ?Agreement?), by and among Dr. |
|
| July 29, 2022 |
Exhibit A JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree that only one statement containing the information required by Schedule 13D and any further amendments thereto needs to be filed with respect to the beneficial ownership by each of the undersigned of the ordinary shares of Aesthetic Medical International Holdings Group Limited, a Cayman Islands company, and further agree that this Joint Filing Agreement be included as an exhibit to the Schedule 13D. |
|
| July 29, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* Aesthetic Medical International Holdings Group Limited (Name of Issuer) Ordinary shares, par value $0.001 per share (Title of Class of Securities) 00809M104** (CUSIP Number) Vistra (Cayman) Limited P. O. Box 31119 Grand Pavilion, Hibiscus Way 802 West |
|
| July 29, 2022 |
Joint Filing Agreement between Ding Wenting and Jubilee Set Investments Limited Exhibit A JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree that only one statement containing the information required by Schedule 13D and any further amendments thereto needs to be filed with respect to the beneficial ownership by each of the undersigned of the ordinary shares of Aesthetic Medical International Holdings Group Limited, a Cayman Islands company, and further agree that this Joint Filing Agreement be included as an exhibit to the Schedule 13D. |
|
| July 29, 2022 |
Exhibit B Aesthetic Medical International Holdings Group Limited AND Zhou Pengwu Ding Wenting AND Hainan Oriental Jiechuang Investment Partnership (Limited Partnership) SUBSCRIPTION AGREEMENT relating to Aesthetic Medical International Holdings Group Limited , 2022 1 Table of Content 1. |
|
| July 29, 2022 |
Exhibit?E ? CO-SALE AGREEMENT ? THIS CO-SALE AGREEMENT (this ?Agreement?) is being executed and delivered as a deed on July?20, 2022, by and among: ? 1. |
|
| July 29, 2022 |
Exhibit D Aesthetic Medical International Holdings Group Limited And Seefar Global Holdings Limited Jubilee Set Investments Limited Zhou Pengwu Ding Wenting And Peak Asia Investment Holdings V Limited And Hawyu (HK) Limited Australia Wanda International Company Limited Hainan Oriental Jiechuang Investment Partnership (Limited Partnership) SHAREHOLDERS? AGREEMENT Relating to Aesthetic Medical International Holdings Group Limited , 2022 1 TABLE OF CONTENTS Page SHAREHOLDERS 'AGREEMENT 3 I. |
|
| July 20, 2022 |
WARRANT TO PURCHASE ORDINARY SHARES OF AESTHETIC MEDICAL INTERNATIONAL HOLDINGS GROUP LIMITED Exhibit 99.6 THIS WARRANT AND THE SECURITIES ISSUABLE UPON THE EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE ?ACT?), UNDER THE LAWS OF THE CAYMAN ISLANDS, OR UNDER ANY OTHER SECURITIES LAWS. THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED, OFFERED FOR SALE, PLEDGED, HYPOTHECATED, OR RES |
|
| July 20, 2022 |
Exhibit 99.4 Aesthetic Medical International Holdings Group Limited And Seefar Global Holdings Limited Jubilee Set Investments Limited Zhou Pengwu Ding Wenting And Peak Asia Investment Holdings V Limited And Hawyu (HK) Limited Australia Wanda International Company Limited Hainan Oriental Jiechuang Investment Partnership (Limited Partnership) SHAREHOLDERS? AGREEMENT Relating to Aesthetic Medical In |
|
| July 20, 2022 |
Exhibit 99.3 Aesthetic Medical International Holdings Group Limited AND Zhou Pengwu Ding Wenting AND Hainan Oriental Jiechuang Investment Partnership (Limited Partnership) SUBSCRIPTION AGREEMENT relating to Aesthetic Medical International Holdings Group Limited , 2022 1 Table of Content 1. Definitions and Interpretation 4 2. This Private Placement/This Offering 8 3. Conditions Precedent to this Pr |
|
| July 20, 2022 |
WARRANT TO PURCHASE ORDINARY SHARES OF AESTHETIC MEDICAL INTERNATIONAL HOLDINGS GROUP LIMITED Exhibit 99.8 THE WARRANTS HAVE NOT BEEN AND WILL NOT BE REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE ?U.S. SECURITIES ACT?), OR THE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES. THIS WARRANT MAY NOT BE EXERCISED IN THE UNITED STATES OR BY OR ON BEHALF OF, OR FOR THE ACCOUNT OR BENEFIT OF, A U.S. PERSON OR A PERSON IN THE UNITED STATES UNLESS AN EXEMPTION FROM THE |
|
| July 20, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2022 Commission File Number: 001-39088 Aesthetic Medical International Holdings Group Limited 1122 Nanshan Boulevard Nanshan District, Shenzhen Guangdong Province, China 518052 (Address of |
|
| July 20, 2022 |
Exhibit 99.2 Australia Wanda International Company Limited AND Aesthetic Medical International Holdings Group Limited AND Seefar Global Holdings Limited Jubilee Set Investments Limited Pengai Hospital Management Corporation Zhou Pengwu Ding Wenting relating to SHARE PURCHASE AGREEMENT , 2022 TABLE OF CONTENTS Page Ariticles I Definitions and Interpretation 5 Section 1.1 Definitions 5 Section 1.2 I |
|
| July 20, 2022 |
Exhibit 99.5 COOPERATION AGREEMENT This COOPERATION AGREEMENT (this ?Agreement?), dated as of , 2022 (this ?Agreement?), by and among Peak Asia Investment Holdings V Limited, a company incorporated under the laws of the British Virgin Islands (?ADV?), Beacon Technology Investment Holdings Limited, a company incorporated under the laws of Hong Kong (?Beacon?), Hainan Oriental Jiechuang Investment P |
|
| July 20, 2022 |
WARRANT TO PURCHASE ORDINARY SHARES OF AESTHETIC MEDICAL INTERNATIONAL HOLDINGS GROUP LIMITED Exhibit 99.7 THIS WARRANT AND THE SECURITIES ISSUABLE UPON THE EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE ?ACT?), UNDER THE LAWS OF THE CAYMAN ISLANDS, OR UNDER ANY OTHER SECURITIES LAWS. THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED, OFFERED FOR SALE, PLEDGED, HYPOTHECATED, OR RES |
|
| July 20, 2022 |
Exhibit 99.1 Aesthetic Medical International and Investors Entered into a Share Purchase Agreement, a Subscription Agreement, a Shareholders? Agreement and a Cooperation Agreement SHENZHEN, China, July 20, 2022, (GLOBE NEWSWIRE) - Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the ?Company? or ?AIH?), a leading provider of aesthetic medical services in China, today announced |
|
| July 14, 2022 |
Aesthetic Medical International Announced Closing of RMB100 Million Private Placement Exhibit 99.1 Aesthetic Medical International Announced Closing of RMB100 Million Private Placement SHENZHEN, China, July 13, 2022 (GLOBE NEWSWIRE) - Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the ?Company? or ?AIH?), a leading provider of aesthetic medical services in China, is pleased to announce that further to its press release on May 31, 2022, the Company has closed |
|
| July 14, 2022 |
6-K 1 tm2220696d16k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2022 Commission File Number: 001-39088 Aesthetic Medical International Holdings Group Limited 1122 Nanshan Boulevard Nanshan District, Shenzhen Guangdong P |
|
| July 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 1) Aesthetic Medical International Holdings Group Limited (Name of Issuer) Ordinary shares, par value US$ 0.001 per share (Title of Class of Securities) 00809M104* (CUSIP Number) Ning Liu, Esq. King & Wood Mallesons 50th Floor, 500 Fifth Avenue New York, N |
|
| June 29, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2022 Commission File Number: 001-39088 Aesthetic Medical International Holdings Group Limited 1122 Nanshan Boulevard Nanshan District, Shenzhen Guangdong Province, China 518052 (Address of |
|
| June 29, 2022 |
Aesthetic Medical International Reports First Quarter 2022 Unaudited Financial Results Exhibit 99.1 Aesthetic Medical International Reports First Quarter 2022 Unaudited Financial Results Shenzhen, China, June 29, 2022 (GLOBE NEWSWIRE) ? Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the ?Company? or ?AIH?), a leading provider of aesthetic medical services in China, announced its unaudited financial results for the first quarter ended March 31, 2022. Dr. Zhou P |
|
| June 17, 2022 |
As filed with the Securities and Exchange Commission on June 17, 2022 TABLE OF CONTENTS As filed with the Securities and Exchange Commission on June 17, 2022 REGISTRATION NO: 333- ????????? ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| June 17, 2022 |
Exhibit 107 Calculation of Filing Fee Tables Form F-3 (Form Type) Aesthetic Medical International Holdings Group Limited (Exact name of registrant as specified in its charter) Table 1 ? Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Share Maximum Aggregate Offering Price Fee Rate Amount of Registration fee Equity Ordinary Shares, par value $0. |
|
| June 10, 2022 |
Exhibit B English Translation of Share Subscription Agreement (as amended in 2022) AESTHETIC MEDICAL INTERNATIONAL HOLDINGS GROUP LIMITED SHENZHEN PENGAI HOSPITAL INVESTMENT MANAGEMENT CO. |
|
| June 10, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D* Under the Securities Exchange Act of 1934 Aesthetic Medical International Holdings Group Limited (Name of Issuer) Ordinary shares, par value US$ 0.001 per share (Title of Class of Securities) 00809M104** (CUSIP Number) Ning Liu, Esq. King & Wood Mallesons 50th Floor, 500 Fifth Avenue New York, NY 10110 United Sta |
|
| June 10, 2022 |
Joint Filing Agreement JOINT FILING AGREEMENT Exhibit A Joint Filing Agreement JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree that only one statement containing the information required by Schedule 13D and any further amendments thereto needs to be filed with respect to the beneficial ownership by each of the undersigned of the ordinary shares of Aesthetic Medical International Holdings Group Limited, a Cayman Islands company, and further agree that this Joint Filing Agreement be included as an exhibit to the Schedule 13D. |
|
| May 31, 2022 |
Exhibit 99.2 AESTHETIC MEDICAL INTERNATIONAL HOLDINGS GROUP LIMITED SHENZHEN PENGAI HOSPITAL INVESTMENT MANAGEMENT CO., LTD. AND ZHOU Pengwu DING Wenting AND LAFANG CHINA CO., LTD. HAINAN RUNMING BIOTECHNOLOGY CO., LTD. HAWYU (HK) LIMITED in relation to SHARE SUBSCRIPTION AGREEMENT OF AESTHETIC MEDICAL INTERNATIONAL HOLDINGS GROUP LIMITED (AS AMENDED IN 2022) May, 2022 Content 1. Definitions And I |
|
| May 31, 2022 |
Our current report on Form 6-K furnished with the SEC on May 31, 2022; UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2022 Commission File Number: 001-39088 Aesthetic Medical International Holdings Group Limited 1122 Nanshan Boulevard Nanshan District, Shenzhen Guangdong Province, China 518052 (Address of |
|
| May 31, 2022 |
Exhibit 99.1 Aesthetic Medical International and Investors Entered into an Amendment to a Share Subscription Agreement SHENZHEN, China, May 31, 2022 (GLOBE NEWSWIRE) - Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the ?Company? or ?AIH?), a leading provider of aesthetic medical services in China, today announced that the Company, founder and senior executive of the Company |
|
| May 16, 2022 |
Exhibit 13.1 Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of Aesthetic Medical International Holdings Group Limited (the “Company”) on Form 20-F for the year ended December 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Zhou Pengwu, Chief Executive |
|
| May 16, 2022 |
Consent of Union Power HK CPA Limited Exhibit 15.2 ? CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ? We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-237835) of Aesthetic Medical International Holdings Group Limited of our report dated May 13, 2022 relating to the consolidated financial statements of Aesthetic Medical International Holdings Group Limited, which appears |
|
| May 16, 2022 |
Exhibit 13.2 Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of Aesthetic Medical International Holdings Group Limited (the “Company”) on Form 20-F for the year ended December 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Wu Guanhua, Chief Financial |
|
| May 16, 2022 |
Exhibit 12.2 Certification by the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Wu Guanhua, certify that: 1. I have reviewed this annual report on Form 20-F of Aesthetic Medical International Holdings Group Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to |
|
| May 16, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F Table of Contents ? ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| May 16, 2022 |
Exhibit 12.1 Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Zhou Pengwu, certify that: 1.I have reviewed this annual report on Form 20-F of Aesthetic Medical International Holdings Group Limited; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to m |
|
| May 16, 2022 |
Exhibit 16.1 May 13, 2022 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Commissioners: We have read the statements made by Aesthetic Medical International Holdings Group Limited (copy attached), which we understand will be filed with the Securities and Exchange Commission, pursuant to Item 16F of Form 20-F of Aesthetic Medical International Holdings Group Limited dated |
|
| May 16, 2022 |
Consent of Han Kun Law Offices Exhibit 15.1 ? ? ? ? ? ? Date: May 13, 2022 ? Aesthetic Medical International Holdings Group Limited 1122 Nanshan Boulevard, Nanshan District, Shenzhen, Guangdong Province, China 518052 ? Dear Sirs/Madams, ? We hereby consent to the reference to our firm in Aesthetic Medical International Holdings Group Limited?s annual report on Form 20-F for the fiscal year ended December 31, 2021, which will be |
|
| May 13, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2022 Commission File Number: 001-39088 Aesthetic Medical International Holdings Group Limited 1122 Nanshan Boulevard Nanshan District, Shenzhen Guangdong Province, China 518052 (Address of |
|
| May 13, 2022 |
Aesthetic Medical International Reports Fiscal Year 2021 Unaudited Financial Results Exhibit 99.1 Aesthetic Medical International Reports Fiscal Year 2021 Unaudited Financial Results SHENZHEN, China, May 13, 2022 (GLOBE NEWSWIRE) - Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the ?Company? or ?AIH?), a leading provider of aesthetic medical services in China, announced its unaudited financial results for the fiscal year ended December 31, 2021. Dr. Zhou Pen |
|
| April 29, 2022 |
Aesthetic Medical International Holdings Group Limited (Name of Registrant as Specified in Charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ? Form 10-K x Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-CEN ? Form N-CSR For Period Ended: December 31, 2021 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10-Q For the Transition Pe |
|
| March 17, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2022 Commission File Number: 001-39088 Aesthetic Medical International Holdings Group Limited 1122 Nanshan Boulevard Nanshan District, Shenzhen Guangdong Province, China 518052 (Address o |
|
| March 17, 2022 |
Exhibit 99.1 Aesthetic Medical International Announces Medical Risk Control System Upgrade to Support Healthy Development of the Aesthetic Medical Industry SHENZHEN, China, March 17, 2022 (GLOBE NEWSWIRE) - Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the ?Company? or ?AIH?), a leading provider of aesthetic medical services in China, is pleased to announce that it has upgr |
|
| February 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Aesthetic Medical International Holdings Group Limited (Name of Issuer) Ordinary shares, par value US$0.001 per share (Title of Class of Securities) 00809M104** (CUSIP Number) December 31, 2021 (Date of Event which Requires Filing of this Statement) Chec |
|
| February 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Aesthetic Medical International Holdings Group Limited (Name of Issuer) Ordinary shares, par value US$0.001 per share (Title of Class of Securities) 00809M104** (CUSIP Number) December 31, 2019 (Date of Event which Requires Filing of this Statement) Check |
|
| February 18, 2022 |
Aesthetic Medical International Announces Change of Board Members and Committee Composition Exhibit 99.1 Aesthetic Medical International Announces Change of Board Members and Committee Composition Shenzhen, China, February 18, 2022 (GLOBE NEWSWIRE) - Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the ?Company? or ?AIH?), a leading provider of aesthetic medical services in China, today announced that Mr. Feng Lu has resigned from his position as the independent Dire |
|
| February 18, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2022 Commission File Number: 001-39088 Aesthetic Medical International Holdings Group Limited 1122 Nanshan Boulevard Nanshan District, Shenzhen Guangdong Province, China 518052 (Addres |
|
| January 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2022 Commission File Number: 001-39088 Aesthetic Medical International Holdings Group Limited 1122 Nanshan Boulevard Nanshan District, Shenzhen Guangdong Province, China 518052 (Address |
|
| January 28, 2022 |
Exhibit 99.1 Aesthetic Medical International Holdings Group Limited Announces Change in Certified Public Accountant Shenzhen, China, January 28, 2022 (GLOBE NEWSWIRE) - Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the ?Company? or ?AIH?), a leading provider of aesthetic medical services in China, today announced that the appointment of Union Power HK CPA Limited (the ?Unio |
|
| December 6, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2021 Commission File Number: 001-39088 Aesthetic Medical International Holdings Group Limited 1122 Nanshan Boulevard Nanshan District, Shenzhen Guangdong Province, China 518052 (Addres |
|
| December 6, 2021 |
Exhibit 99.1 Aesthetic Medical International Announces Business Updates on Newly-acquired Non-surgical Business in Guangzhou Shenzhen, China, December 6, 2021 (GLOBE NEWSWIRE) - Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the ?Company? or ?AIH?), a leading provider of aesthetic medical services in China, today announced the operational updates on its newly-acquired non-su |
|
| December 2, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2021 Commission File Number: 001-39088 Aesthetic Medical International Holdings Group Limited 1122 Nanshan Boulevard Nanshan District, Shenzhen Guangdong Province, China 518052 (Addres |
|
| December 2, 2021 |
Aesthetic Medical International Announces Business Updates Exhibit 99.1 Aesthetic Medical International Announces Business Updates Shenzhen, China, December 1, 2021 (GLOBE NEWSWIRE) - Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the ?Company? or ?AIH?), a leading provider of aesthetic medical services in China, today announces business updates for November 2021. Benefited from the Company?s successful promotional events during the |
|
| November 16, 2021 |
EX-99.1 2 tm2133084d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Aesthetic Medical International Holdings Group Limited Reports Second Quarter and First Half of 2021 Unaudited Financial Results Shenzhen, China, November 16 2021 (GLOBE NEWSWIRE) - Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, today |
|
| November 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2021 Commission File Number: 001-39088 Aesthetic Medical International Holdings Group Limited 1122 Nanshan Boulevard Nanshan District, Shenzhen Guangdong Province, China 518052 (Addres |
|
| September 30, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2021 Commission File Number: 001-39088 Aesthetic Medical International Holdings Group Limited 1122 Nanshan Boulevard Nanshan District, Shenzhen Guangdong Province, China 518052 (Addre |
|
| September 30, 2021 |
Aesthetic Medical International Announces Restructuring Plans to Optimize Business Operations Exhibit 99.1 Aesthetic Medical International Announces Restructuring Plans to Optimize Business Operations Shenzhen, China, September 30, 2021 (GLOBE NEWSWIRE) - Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the ?Company? or ?AIH?), a leading provider of aesthetic medical services in China, today announced a preliminary plan for business strategies and restructuring. In lig |
|
| June 24, 2021 |
Exhibit 99.1 Aesthetic Medical International Holdings Group Limited Reports First Quarter 2021 Unaudited Financial Results Shenzhen, China, June 24, 2021 (GLOBE NEWSWIRE) - Aesthetic Medical International Holdings Group Limited (the ?Company? or Nasdaq: AIH), a leading provider of aesthetic medical services in China, today announced its unaudited financial results for the first quarter ended March |
|
| June 24, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2021 Commission File Number: 001-39088 Aesthetic Medical International Holdings Group Limited 1122 Nanshan Boulevard Nanshan District, Shenzhen Guangdong Province, China 518052 (Address of |
|
| May 24, 2021 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Act of 1934 (Amendment No. 1)* Aesthetic Medical International Holdings Group Limited (Name of Issuer) Ordinary shares, par value $0.001 per share (Title of Class of Securities) 00809M104** (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to |
|
| May 17, 2021 |
Exhibit 99.2 LAFANG CHINA CO., LTD AND AESTHETIC MEDICAL INTERNATIONAL HOLDINGS GROUP LIMITED SHENZHEN PENGAI HOSPITAL INVESTMENT MANAGEMENT CO., LTD SHARE SUBSCRIPTION AGREEMENT May 16, 2021 TABLE OF CONTENTS 1. Definitions and Interpretations 3 2. This Private Placement/This Offering 7 3. Conditions Precedent to this Private Placement 8 4. Closing 10 5. Representations and Warranties 12 6. Coven |
|
| May 17, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2021 Commission File Number: 001-39088 Aesthetic Medical International Holdings Group Limited 1122 Nanshan Boulevard Nanshan District, Shenzhen Guangdong Province, China 518052 (Address of |
|
| May 17, 2021 |
Exhibit 99.1 Aesthetic Medical International Holdings Group Limited Announces USD$15.1 Million Private Placement with Lafang China Co., Ltd Shenzhen, China, May 17, 2021 (GLOBE NEWSWIRE) - Aesthetic Medical International Holdings Group Limited (the ?Company? or Nasdaq: AIH), a leading provider of aesthetic medical services in China, today announced that it has entered into a definitive share subsc |
|
| May 17, 2021 |
Undertaking by Control Persons Exhibit 99.3 Undertaking by Control Persons I (ZHOU Pengwu) and my spouse (DING Wenting) (collectively, the ?Covenantor?, ?we? or ?us?) are the joint control persons of both of Aesthetic Medical International Holdings Group Limited (?AIH?) and Shenzhen Pengai Hospital Investment Management Co., Ltd. (?Pengai?) (AIH, Pengai and their respective subsidiaries and affiliated companies are collectively |
|
| April 30, 2021 |
Exhibit 4.62 ECONOMIC INTEREST TRANSFER AGREEMENT This Economic Interest Transfer Agreement (the ?Agreement?) is entered into by and among the parties below as of April 23, 2021 in Shenzhen, the People?s Republic of China (?China? or the ?PRC?): (1) Zhou Pengwu (the ?Transferor?), a Chinese citizen with the Identification No.: 360302195410010513; (2) Shenzhen Pengai Hospital Investment Management |
|
| April 30, 2021 |
EX-4.56 6 a21-51551ex4d56.htm EX-4.56 Exhibit 4.56 Exclusive Option Agreement This Exclusive Option Agreement (this “Agreement”) is executed by and among the following parties as of April 23, 2021 in Shenzhen, the People’s Republic of China (“China” or the “PRC”): Party A: Shenzhen Pengai Hospital Investment Management Co., Ltd., a limited liability company duly incorporated and validly existing u |
|
| April 30, 2021 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) o REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES ACT OF 1934 OR x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SEC |
|
| April 30, 2021 |
Exhibit 4.61 Loan Agreement This Loan Agreement (the ?Agreement?) is entered into by and between the parties below as of April 23, 2021 in Shenzhen, the People?s Republic of China (?China? or the ?PRC?): (1) Shenzhen Pengai Hospital Investment Management Co., Ltd. (the ?Lender?), a limited liability company incorporated and existing under the laws of the PRC, with the address at South 4/F, Buildin |
|
| April 30, 2021 |
Exhibit 4.65 Power of Attorney The undersigned, Zhou Pengwu, a PRC citizen with Identification No.: 360302195410010513, execute this Power of Attorney on April 23, 2021, which becomes effective as of the date hereof. As of the date of the Power of Attorney I hold 25% of the equity interests in Jiangsu Liangyan Hospital Management Co., Ltd. (the ?Company?). For the equity interests in the Company t |
|
| April 30, 2021 |
Exhibit 4.55 ECONOMIC INTEREST TRANSFER AGREEMENT This Economic Interest Transfer Agreement (the ?Agreement?) is entered into by and among the parties below as of April 23, 2021 in Shenzhen, the People?s Republic of China (?China? or the ?PRC?): (1) Zhou Pengwu (the ?Transferor?), a Chinese citizen with the Identification No.: 360302195410010513; (2) Shenzhen Pengai Hospital Investment Management |
|
| April 30, 2021 |
Exhibit 12.2 Certification by the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Wu Guanhua, certify that: 1. I have reviewed this annual report on Form 20-F of Aesthetic Medical International Holdings Group Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to |
|
| April 30, 2021 |
Exhibit 4.63 Exclusive Option Agreement This Exclusive Option Agreement (this ?Agreement?) is executed by and among the following parties as of April 23, 2021 in Shenzhen, the People?s Republic of China (?China? or the ?PRC?): Party A: Shenzhen Pengai Hospital Investment Management Co., Ltd., a limited liability company duly incorporated and validly existing under the laws of the PRC, with the add |
|
| April 30, 2021 |
EXHIBIT 4.57 Equity Interest Pledge Agreement This Equity Interest Pledge Agreement (this ?Agreement?) is entered into by and among the following parties on April 23, 2021 in Shenzhen, the People?s Republic of China (?China? or the ?PRC?): Party A: Shenzhen Pengai Hospital Investment Management Co., Ltd. (the ?Pledgee?), a limited liability company incorporated and existing under the PRC laws, wit |
|
| April 30, 2021 |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Exhibit 15.2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-237835) of Aesthetic Medical International Holdings Group Limited of our report dated April 30, 2021 relating to the financial statements, which appears in this Form 20-F. /s/ PricewaterhouseCoopers Zhong Tian LLP Shenzhen, th |
|
| April 30, 2021 |
Exhibit 4.53 Equity transfer agreement This equity transfer agreement (this Agreement) is made on 2021 Year April Month 23 Signed in Shenzhen (1) Transferor: Shenzhen Peng?ai Hospital Investment Management Co., Ltd Address:South, 4th floor, building 7a, Nanyou fourth industrial zone, Nanshan District, Shenzhen ID number: 91440300769184144M (2) Transferee: Zhou pengwu Address:7-F, Tianmao Pavilion, |
|
| April 30, 2021 |
Exhibit 13.1 Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of Aesthetic Medical International Holdings Group Limited (the ?Company?) on Form 20-F for the year ended December 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the ?Report?), I, Zhou Pengwu, Chief Executive |
|
| April 30, 2021 |
EXHIBIT 4.64 Equity Interest Pledge Agreement This Equity Interest Pledge Agreement (this ?Agreement?) is entered into by and among the following parties on April 23, 2021 in Shenzhen, the People?s Republic of China (?China? or the ?PRC?): Party A: Shenzhen Pengai Hospital Investment Management Co., Ltd. (the ?Pledgee?), a limited liability company incorporated and existing under the PRC laws, wit |
|
| April 30, 2021 |
Exhibit 4.60 Equity transfer agreement This equity transfer agreement (this Agreement) is made on April 23, 2021 Signed in Shenzhen (1) Transferor: Shenzhen Pengai Hospital Investment Management Co., Ltd Address:South, 4th floor, building 7a, Nanyou fourth industrial zone, Nanshan District, Shenzhen ID number: 91440300769184144M (2) Transferee: Zhou pengwu Address:7-F, Tianmao Pavilion, Guodu buil |
|
| April 30, 2021 |
EX-2.8 2 a21-51551ex2d8.htm EX-2.8 Exhibit 2.8 Description of rights of each class of securities registered under Section 12 of the Securities Exchange Act of 1934 (the “Exchange Act”) American Depositary Shares (“ADSs”), each representing three ordinary shares of Aesthetic Medical International Holdings Group Limited (“we,” “our,” “our company,” or “us”), are listed and traded on the Nasdaq Globa |
|
| April 30, 2021 |
Exhibit 13.2 Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of Aesthetic Medical International Holdings Group Limited (the ?Company?) on Form 20-F for the year ended December 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the ?Report?), I, Wu Guanhua, Chief Financial |
|
| April 30, 2021 |
Exhibit 12.1 Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Zhou Pengwu, certify that: 1. I have reviewed this annual report on Form 20-F of Aesthetic Medical International Holdings Group Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to |
|
| April 30, 2021 |
English translation of spousal consent letter dated April 23, 2021 by Ding Wenting EX-4.66 16 a21-51551ex4d66.htm EX-4.66 Exhibit 4.66 Consent Letter The undersigned, Ding Wenting, a citizen of the People’s Republic of China (“China” or the “PRC”) with the PRC Identification No.: 430302196503071529, is the lawful spouse of Zhou Pengwu, a PRC citizen with the PRC Identification No.: 360302195410010513. I hereby unconditionally and irrevocably agree on the execution of the followi |
|
| April 30, 2021 |
Exhibit 4.59 ??? Consent Letter The undersigned, Ding Wenting , a citizen of the People?s Republic of China (?China? or the ?PRC?) with the PRC Identification No.: 430302196503071529, is the lawful spouse of Zhou Pengwu, a PRC citizen with the PRC Identification No.: 360302195410010513. I hereby unconditionally and irrevocably agree on the execution of the following documents (hereinafter referred |
|
| April 30, 2021 |
Exhibit 4.58 Power of Attorney The undersigned, Zhou Pengwu, a PRC citizen with Identification No.: 360302195410010513, execute this Power of Attorney on April 23, 2021, which becomes effective as of the date hereof. As of the date of the Power of Attorney I hold 25% of the equity interests in Beijing Aomei Yixin Investment Consultation Co., Ltd. (the ?Company?). For the equity interests in the Co |
|
| April 30, 2021 |
Exhibit 4.54 Loan Agreement This Loan Agreement (the ?Agreement?) is entered into by and between the parties below as of April 23, 2021 in Shenzhen, the People?s Republic of China (?China? or the ?PRC?): (1) Shenzhen Pengai Hospital Investment Management Co., Ltd. (the ?Lender?), a limited liability company incorporated and existing under the laws of the PRC, with the address at South 4/F, Buildin |
|
| April 30, 2021 |
Exhibit 15.1 Date: April 30, 2021 Aesthetic Medical International Holdings Group Limited 1122 Nanshan Boulevard, Nanshan District, Shenzhen, Guangdong Province, China 518052 Dear Sirs/Madams, We hereby consent to the reference to our firm and the summary of our opinion under the headings, ?Item 3. Key Information ? 3.D. Risk Factors - Risks relating to our corporate structure,? ?Item 4. Informatio |
|
| April 20, 2021 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2021 Commission File Number: 001-39088 Aesthetic Medical International Holdings Group Limited 4068 Qiaoxiang Road, Nanshan District Shenzhen, Guangdong Province, 518053 People?s Republic |
|
| April 20, 2021 |
EX-99.1 2 tm2113503d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Aesthetic Medical International Holdings Group Limited Reports Fourth Quarter and Fiscal Year 2020 Unaudited Financial Results Shenzhen, China, April 20, 2021 — Aesthetic Medical International Holdings Group Limited (the “Company” or Nasdaq: AIH), a leading provider of aesthetic medical services in China, today announces its unaudited finan |
|
| March 30, 2021 |
EX-99.1 2 a21-113281ex99d1.htm EX-99.1 Exhibit 99.1 Aesthetic Medical International Holdings Group Limited Announces Changes in its Committee Composition Shenzhen, China, March 30, 2021 (GLOBE NEWSWIRE) — Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, today announced that Mr. Tsang Eric Chi W |
|
| March 30, 2021 |
Current Report of Foreign Issuer - 6-K 6-K 1 a21-1132816k.htm 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2021 Commission File Number: 001-39088 Aesthetic Medical International Holdings Group Limited 4068 Qiaoxiang Road, Nanshan District Shenzhen, Guangdong Province |
|
| January 5, 2021 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2021 Commission File Number: 001-39088 Aesthetic Medical International Holdings Group Limited 4068 Qiaoxiang Road, Nanshan District Shenzhen, Guangdong Province, 518053 People’s Republi |
|
| January 5, 2021 |
Exhibit 99.1 Aesthetic Medical International Holdings Group Limited Announces Termination of Agreement to Acquire Controlling Interest in Guangdong Hanfei Investment Management Co., Ltd. Shenzhen, China, January 4, 2021 (GLOBE NEWSWIRE) - Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, today a |
|
| November 30, 2020 |
Current Report of Foreign Issuer - 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2020 Commission File Number: 001-39088 Aesthetic Medical International Holdings Group Limited 4068 Qiaoxiang Road, Nanshan District Shenzhen, Guangdong Province, 518053 People’s Republ |
|
| November 30, 2020 |
Exhibit 99.1 Aesthetic Medical International Holdings Group Limited Reports Third Quarter 2020 Unaudited Financial Results Shenzhen, China, November 30, 2020 — Aesthetic Medical International Holdings Group Limited (the “Company” or Nasdaq: AIH), a leading provider of aesthetic medical services in China, today announces its unaudited financial results for the third quarter ended September 30, 2020 |
|
| October 13, 2020 |
Exhibit 99.1 Aesthetic Medical International Holdings Group Limited Announces US$6.0 Million Share Repurchase Program Shenzhen, China, October 13, 2020 — Aesthetic Medical International Holdings Group Limited (the “Company”) (NASDAQ: AIH), a leading provider of aesthetic medical services in China, today announced that its board of directors has authorized a share repurchase program under which the |
|
| October 13, 2020 |
Current Report of Foreign Issuer - 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2020 Commission File Number: 001-39088 Aesthetic Medical International Holdings Group Limited 4068 Qiaoxiang Road, Nanshan District Shenzhen, Guangdong Province, 518053 People’s Republi |
|
| September 25, 2020 |
EX-99.1 2 a20-317071ex99d1.htm EX-99.1 Exhibit 99.1 Aesthetic Medical International Holdings Group Limited Reports Second Quarter 2020 Unaudited Financial Results Shenzhen, China, September 25, 2020 — Aesthetic Medical International Holdings Group Limited (the “Company” or Nasdaq: AIH), a leading provider of aesthetic medical services in China, today announces its unaudited financial results for t |
|
| September 25, 2020 |
Current Report of Foreign Issuer - 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2020 Commission File Number: 001-39088 Aesthetic Medical International Holdings Group Limited 4068 Qiaoxiang Road, Nanshan District Shenzhen, Guangdong Province, 518053 People’s Repub |
|
| September 22, 2020 |
EXHIBIT A JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to ordinary shares, par value $0. |
|
| September 22, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. ) Aesthetic Medical International Holdings Group Limited (Name of Issuer) Ordinary shares, par value $0.001 per share (Title of Class of Securities) 00809M104** (CUSIP Number) Vistra (Cayman) Limited P. O. Box 31119 Grand Pavilion, Hibiscus Way 802 West Bay |
|
| September 15, 2020 |
Current Report of Foreign Issuer - 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2020 Commission File Number: 001-39088 Aesthetic Medical International Holdings Group Limited 4068 Qiaoxiang Road, Nanshan District Shenzhen, Guangdong Province, 518053 People’s Repub |
|
| September 15, 2020 |
Exhibit 99.1 Aesthetic Medical International Holdings Group Limited Announces Results of Annual General Meeting of Shareholders Shenzhen, China, September 15, 2020 — Aesthetic Medical International Holdings Group Limited (the “Company” or Nasdaq: AIH), a leading provider of aesthetic medical services in China, today announced that it held its Annual General Meeting of Shareholders (the “2020 AGM”) |
|
| September 8, 2020 |
Exhibit 99.4 EXECUTION VERSION CONVERTIBLE NOTE PURCHASE AGREEMENT between Peak Asia Investment Holdings V Limited and Aesthetic Medical International Holdings Group Limited and Beacon Technology Investment Holdings Limited Dated , 2020 TABLE OF CONTENTS Page SECTION 1 INTERPRETATION 1 SECTION 2 SALE AND PURCHASE OF THE CONVERTIBLE NOTES 8 SECTION 3 CONDITIONS PRECEDENT TO CLOSINGS 9 SECTION 4 CLO |
|
| September 8, 2020 |
Exhibit 99.2 AESTHETIC MEDICAL INTERNATIONAL HOLDINGS GROUP LIMITED NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON SEPTEMBER 15, 2020 Dear Shareholders, Notice is hereby given that Aesthetic Medical International Holdings Group Limited, a Cayman Islands exempted company (the “Company”), will hold its annual general meeting of shareholders (the “Meeting”) at Room 1202, Building B, Z |
|
| September 8, 2020 |
Current Report of Foreign Issuer - 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2020 Commission File Number: 001-39088 Aesthetic Medical International Holdings Group Limited 4068 Qiaoxiang Road, Nanshan District Shenzhen, Guangdong Province, 518053 People’s Repub |
|
| September 8, 2020 |
Exhibit 99.3 AESTHETIC MEDICAL INTERNATIONAL HOLDINGS GROUP LIMITED (Incorporated in the Cayman Islands as an exempted company with limited liability) (Nasdaq Ticker: AIH) PROXY STATEMENT (or any adjourned meeting thereof) to Be Held on September 15, 2020 General Our Board of Directors is soliciting proxies for an annual general meeting of shareholders (the “Meeting”) to be held at 3 p.m. (China S |
|
| September 8, 2020 |
Exhibit 99.1 Aesthetic Medical International Holdings Group Limited to Hold Annual General Meeting on September 15, 2020 Shenzhen, China, September 5, 2020 — Aesthetic Medical International Holdings Group Limited (the “Company” or Nasdaq: AIH), a leading provider of aesthetic medical services in China, today announced that it will hold its 2020 Annual General Meeting of Shareholders (the “AGM”) at |
|
| September 8, 2020 |
Exhibit 99.7 FIRST RANK DEED OF SHARE CHARGE over 51% of shares in PENG OI INVESTMENT (HONG KONG) HOLDINGS LIMITED by DRAGON JADE HOLDINGS LIMITED in favour of PEAK ASIA INVESTMENT HOLDINGS V LIMITED Dated [•] 2020 TABLE OF CONTENTS Page SECTION 1 DEFINITIONS 1 SECTION 2 CHARGE 4 SECTION 3 FURTHER UNDERTAKINGS, REPRESENTATIONS AND WARRANTIES 8 SECTION 4 POWER OF ATTORNEY 10 SECTION 5 DISCHARGE OF |
|
| September 8, 2020 |
PART 1 Equity Interest Pledge Agreement Exhibit 99.8 PART 1 股权质押协议 Equity Interest Pledge Agreement 本股权质押协议（下称”本协议”）由下列各方于2020年【*】月【*】日（下称”签署日”）签订： This Equity Interest Pledge Agreement (this “Agreement”) has been executed by and among the following parties on [*], 2020 (the “Signing Date”): Peak Asia Investment Holdings V Limited（下称”质权人”），一家依照英属维京群岛法律设立并存续的企业，其注册地址为Flemming House, Wickhams Cay, P.O.Box 662, Road Town, Tortola，英属维尔京群岛； |
|
| September 8, 2020 |
Exhibit 99.5 EXECUTION VERSION Date: 2020 From: Peak Asia Investment Holdings V Limited (“ADV”) 5 Shenton Way, #13-03 UIC Building, Singapore 068808 To: Aesthetic Medical International Holdings Group Limited (the “Company”); Zhou Pengwu (周鹏武) (“Dr. Zhou”); and Ding Wenting (丁文婷) (together with Dr. Zhou, the “Founders”, and the Company and the Founders collectively, the “Warrantors”) c/o Room 1202, |
|
| September 8, 2020 |
Exhibit 99.9 AESTHETIC MEDICAL INTERNATIONAL HOLDINGS GROUP LIMITED (Incorporated in the Cayman Islands as an exempted company with limited liability) (Nasdaq Ticker: AIH) PROXY CARD THIS PROXY CARD IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS OF AESTHETIC MEDICAL INTERNATIONAL HOLDINGS GROUP LIMITED (THE “COMPANY”) FOR AN ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON SEPTEMBER 15, 2020 |
|
| September 8, 2020 |
EX-99.6 7 a20-302621ex99d6.htm EX-99.6 Exhibit 99.6 FIRST RANK DEED OF SHARE CHARGE over 51% of shares in DRAGON JADE HOLDINGS LIMITED 龍翠控股有限公司 by AESTHETIC MEDICAL INTERNATIONAL HOLDINGS GROUP LIMITED in favour of PEAK ASIA INVESTMENT HOLDINGS V LIMITED Dated [•] 2020 TABLE OF CONTENTS Page SECTION 1 DEFINITIONS 1 SECTION 2 SECURITY 3 SECTION 3 FURTHER UNDERTAKINGS, REPRESENTATIONS AND WARRANTIES |
|
| June 26, 2020 |
Current Report of Foreign Issuer - 6-K 6-K 1 a20-2345416k.htm 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2020 Commission File Number: 001-39088 Aesthetic Medical International Holdings Group Limited 1122 Nanshan Boulevard, Nanshan District Shenzhen, Guangdong Provin |
|
| June 26, 2020 |
Exhibit 99.1 Aesthetic Medical International Holdings Group Limited Reports First Quarter 2020 Unaudited Financial Results Shenzhen, China, June 26, 2020 — Aesthetic Medical International Holdings Group Limited (the “Company” or Nasdaq: AIH), a leading provider of aesthetic medical services in China, today announces its unaudited financial results for the first quarter ended March 31, 2020. Dr. Zh |
|
| April 30, 2020 |
Consent of PricewaterhouseCoopers Zhong Tian LLP, Independent Registered Public Accounting Firm Exhibit 15.3 Consent of Independent Registered Public Accounting Firm We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-237835) of Aesthetic Medical International Holdings Group Limited of our report dated April 30, 2020, relating to the consolidated financial statements, which appears in this Form 20-F. /s/ PricewaterhouseCoopers Zhong Tian LLP |
|
| April 30, 2020 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) o REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019. OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) |
|
| April 30, 2020 |
Exhibit 12.1 Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Zhou Pengwu, certify that: 1. I have reviewed this annual report on Form 20-F of Aesthetic Medical International Holdings Group Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to |
|
| April 30, 2020 |
Exhibit 13.1 Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of Aesthetic Medical International Holdings Group Limited (the “Company”) on Form 20-F for the year ended December 31, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Zhou Pengwu, Chief Executive |
|
| April 30, 2020 |
Consent of Conyers Dill & Pearman Exhibit 15.1 30 April 2020 Matter No.: 831154 Doc Ref: 105979226 The Directors Aesthetic Medical International Holdings Group Limited 1122 Nanshan Boulevard Nanshan District, Shenzhen Guangdong Province China 518052 Dear Sirs, Re: Aesthetic Medical International Holdings Group Limited (the “Company”) We refer to the annual report of the Company for the fiscal year ended 31 December 2019 on Form 20 |
|
| April 30, 2020 |
Exhibit 12.2 Certification by the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Wu Guanhua, certify that: 1. I have reviewed this annual report on Form 20-F of Aesthetic Medical International Holdings Group Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to |
|
| April 30, 2020 |
Exhibit 13.2 Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of Aesthetic Medical International Holdings Group Limited (the “Company”) on Form 20-F for the year ended December 31, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Wu Guanhua, Chief Financial |
|
| April 30, 2020 |
Consent of Han Kun Law Offices Exhibit 15.2 Date: April 30, 2020 Aesthetic Medical International Holdings Group Limited Nanshan Road 1122 Nanshan District Shenzhen, 518000 The People’s Republic of China Dear Sirs/Madams, We hereby consent to the reference to our firm in Aesthetic Medical International Holdings Group Limited’s annual report on Form 20-F for the fiscal year ended December 31, 2019, which will be filed by Aestheti |
|
| April 24, 2020 |
Exhibit 4.3 Execution Version DEPOSIT AGREEMENT by and among AESTHETIC MEDICAL INTERNATIONAL HOLDINGS GROUP LIMITED as Issuer, DEUTSCHE BANK TRUST COMPANY AMERICAS as Depositary, AND THE HOLDERS AND BENEFICIAL OWNERS OF AMERICAN DEPOSITARY SHARES EVIDENCED BY AMERICAN DEPOSITARY RECEIPTS ISSUED HEREUNDER Dated as of October 24, 2019 DEPOSIT AGREEMENT DEPOSIT AGREEMENT, dated as of October 24, 2019 |
|
| April 24, 2020 |
As filed with the Securities and Exchange Commission on April 24, 2020 Registration No. |
|
| April 24, 2020 |
Exhibit 99.1 Aesthetic Medical International Holdings Group Limited Reports Fourth Quarter and Fiscal Year 2019 Unaudited Financial Results Shenzhen, China, April 24, 2020 — Aesthetic Medical International Holdings Group Limited (the “Company” or Nasdaq: AIH), a leading provider of aesthetic medical services in China, today announces its financial results for the fourth quarter and fiscal year end |
|
| April 24, 2020 |
Current Report of Foreign Issuer - 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2020 Commission File Number: 001-39088 Aesthetic Medical International Holdings Group Limited 1122 Nanshan Boulevard, Nanshan District Shenzhen, Guangdong Province, 518052 People’s Republ |
|
| April 24, 2020 |
EX-10.2 4 a20-163311ex10d2.htm EX-10.2 Exhibit 10.2 AESTHETIC MEDICAL INTERNATIONAL HOLDINGS GROUP LIMITED 2019 PERFORMANCE INCENTIVE PLAN 1. PURPOSE OF PLAN The purpose of this Aesthetic Medical International Holdings Group Limited 2019 Performance Incentive Plan (this “Plan”) of Aesthetic Medical International Holdings Group Limited, an exempted company organized under the Companies Law of the C |
|
| April 21, 2020 |
EXHIBIT 1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to ordinary shares, par value $0. |
|
| April 21, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934* (Amendment No. ) Aesthetic Medical International Holdings Group Limited (Name of Issuer) Ordinary shares, par value $0.001 per share (Title of Class of Securities) 00809M104** (CUSIP Number) December 31, 2019 (Date of Event which Requires Filing of this Statement) Check t |
|
| March 6, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2020 Commission File Number: 001-39088 Aesthetic Medical International Holdings Group Limited 1122 Nanshan Boulevard, Nanshan District Shenzhen, Guangdong Province, 518052 People’s Republ |
|
| March 6, 2020 |
Aesthetic Medical International Holdings Group Limited Announces Changes to Board of Directors EX-99.1 2 a20-119351ex99d1.htm EX-99.1 Exhibit 99.1 Aesthetic Medical International Holdings Group Limited Announces Changes to Board of Directors Shenzhen, March 6, 2020 — Aesthetic Medical International Holdings Group Limited (the “Company” or Nasdaq: AIH), a leading provider of aesthetic medical services in China, today announced appointment of Ms. Cathy Peng as a member of the Board of Directo |
|
| March 4, 2020 |
AIH / Aesthetic Medical International Holdings Group Ltd. / Ding Wenting - SC 13G Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Act of 1934 (Amendment No. )* Aesthetic Medical International Holdings Group Limited (Name of Issuer) Ordinary shares, par value $0.001 per share (Title of Class of Securities) 00809M104** (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to d |
|
| March 4, 2020 |
EX-99.A 2 a20-115601ex99da.htm EXHIBIT A EXHIBIT A JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13G referred to below) on behalf of each of them of a statement on Schedule 13G (including amendments t |
|
| March 4, 2020 |
EX-99.A 2 a20-115602ex99da.htm EXHIBIT A EXHIBIT A JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13G referred to below) on behalf of each of them of a statement on Schedule 13G (including amendments t |
|
| March 4, 2020 |
AIH / Aesthetic Medical International Holdings Group Ltd. / Zhou Pengwu - SC 13G Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Act of 1934 (Amendment No. )* Aesthetic Medical International Holdings Group Limited (Name of Issuer) Ordinary shares, par value $0.001 per share (Title of Class of Securities) 00809M104** (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to d |
|
| November 26, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2019 Commission File Number: 001-39088 Aesthetic Medical International Holdings Group Limited 1122 Nanshan Boulevard, Nanshan District Shenzhen, Guangdong Province, 518052 People’s Rep |
|
| November 26, 2019 |
EX-99.1 2 a19-238121ex99d1.htm EX-99.1 Exhibit 99.1 Aesthetic Medical International Holdings Group Limited Reports Third Quarter 2019 Unaudited Financial Results Shenzhen, China, November 26, 2019 — Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company”), a leading provider of aesthetic medical services in China, today announces its unaudited financial results for the |
|
| October 25, 2019 |
Use these links to rapidly review the document TABLE OF CONTENTS INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Table of Contents Filed Pursuant to Rule 424(b)4 Registration No. |
|
| October 23, 2019 |
Form of underwriting agreement EX-1.1 2 a2239875zex-11.htm EX-1.1 Exhibit 1.1 AESTHETIC MEDICAL INTERNATIONAL HOLDINGS GROUP LIMITED [·] American Depositary Shares Representing [·] Ordinary Shares (par value US$0.001 per share) Underwriting Agreement [·], 2019 Cantor Fitzgerald & Co. 499 Park Avenue New York, New York 10022 Haitong International Securities Company Limited 22/F, Li Po Chun Chambers 189 Des Voeux Road Central, Ho |
|
| October 23, 2019 |
As filed with the Securities and Exchange Commission on October 23, 2019 QuickLinks - Click here to rapidly navigate through this document As filed with the Securities and Exchange Commission on October 23, 2019 Registration No. |
|
| October 21, 2019 |
AIH / Aesthetic Medical International Holdings Group Ltd. CORRESP - - October 21, 2019 VIA EDGAR Mr. Charles Eastman Mr. Robert S. Littlepage Mr. Joshua Shainess, Esq. Ms. Celeste M. Murphy, Esq. Division of Corporation Finance Office of Telecommunications Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Request for Effectiveness for Aesthetic Medical International Holdings Group Limited (CIK No. 0001757143) Registration Statement on |
|
| October 21, 2019 |
AIH / Aesthetic Medical International Holdings Group Ltd. CORRESP - - Cantor Fitzgerald & Co. 499 Park Avenue New York, New York 10022 Haitong International Securities Company Limited 22/F, Li Po Chun Chambers 189 Des Voeux Road Central, Hong Kong Prime Number Capital, LLC 14 Myrtle Drive Great Neck, New York 11021 As representatives of the prospective underwriters VIA EDGAR October 21, 2019 Office of Telecommunications Division of Corporation Finance U.S. Securitie |
|
| October 15, 2019 |
Proskauer Draft DEPOSIT AGREEMENT by and among Aesthetic medical international holdings group limited as Issuer, DEUTSCHE BANK TRUST COMPANY AMERICAS as Depositary, AND THE HOLDERS AND BENEFICIAL OWNERS OF AMERICAN DEPOSITARY SHARES EVIDENCED BY AMERICAN DEPOSITARY RECEIPTS ISSUED HEREUNDER Dated as of [●], 2019 DEPOSIT AGREEMENT DEPOSIT AGREEMENT, dated as of [●], 2019, by and among (i) Aesthetic Medical International Holdings Group Limited, a company incorporated in the Cayman Islands, with its principal executive office at 1122 Nanshan Boulevard, Nanshan District, Shenzhen, Guangdong Province, China 518052 and its registered office at the offices of Vistra (Cayman) Limited, P. |
|
| October 15, 2019 |
As filed with the Securities and Exchange Commission on , 2019 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-6 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 FOR AMERICAN DEPOSITARY SHARES EVIDENCED BY AMERICAN DEPOSITARY RECEIPTS Aesthetic Medical International Holdings Group Limited (Exact name of issuer of deposited securities as s |
|
| October 15, 2019 |
Exhibit 10.45 Exclusive Option Agreement This Exclusive Option Agreement (this ?Agreement?) is executed by and among the following parties as of October 29, 2018 in Shenzhen, the People?s Republic of China (?China? or the ?PRC?): Party A: Shenzhen Pengai Hospital Investment Management Co., Ltd., a limited liability company duly incorporated and validly existing under the laws of the PRC, with the |
|
| October 15, 2019 |
Exhibit 10.13 Amended and Restated Loan Agreement This Amended and Restated Loan Agreement (the ?Agreement?) is entered into by and between the parties below as of April 1, 2019 in Shenzhen, the People?s Republic of China (?China? or the ?PRC?): (1) Shenzhen Pengai Hospital Investment Management Co., Ltd. (the ?Lender?), a limited liability company incorporated and existing under the laws of the P |
|
| October 15, 2019 |
EX-10.18 19 a2239805zex-1018.htm EX-10.18 Exhibit 10.18 Amended and Restated Consent Letter The undersigned, Ding Wenting, a citizen of the People’s Republic of China (“China” or the “PRC”) with the PRC Identification No.: ###############, is the lawful spouse of Zhou Pengwu, a PRC citizen with the PRC Identification No.: ###############. I hereby unconditionally and irrevocably agree on the execu |
|
| October 15, 2019 |
EX-99.4 60 a2239805zex-994.htm EX-99.4 Exhibit 99.4 The board of Directors Aesthetic Medical International Holdings Group Limited 1122 Nanshan Boulevard Nanshan District, Shenzhen Guangdong Province, China 518052 Date: September 30, 2019 Dear Sirs, CONSENT TO ACT AS INDEPENDENT NON-EXECUTIVE DIRECTOR I, the undersigned, hereby consent to act as an independent non-executive director of the Company, |
|
| October 15, 2019 |
EX-99.3 59 a2239805zex-993.htm EX-99.3 Exhibit 99.3 Aesthetic Medical International Holdings Group Limited 1122 Nanshan Boulevard Nanshan District, Shenzhen Guangdong Province, China Re: Aesthetic Medical International Holdings Group Limited Ladies and Gentlemen, We understand that Aesthetic Medical International Holdings Group Limited (the “Company”) plans to file a registration statement on Form |
|
| October 15, 2019 |
Form of 2019 performance incentive plan of Aesthetic Medical International Holdings Group Limited Exhibit 10.56 AESTHETIC MEDICAL INTERNATIONAL HOLDINGS GROUP LIMITED 2019 PERFORMANCE INCENTIVE PLAN 1. PURPOSE OF PLAN The purpose of this Aesthetic Medical International Holdings Group Limited 2019 Performance Incentive Plan (this ?Plan?) of Aesthetic Medical International Holdings Group Limited, an exempted company organized under the Companies Law of the Cayman Islands, and its successors (the |
|
| October 15, 2019 |
EX-10.54 55 a2239805zex-1054.htm EX-10.54 Exhibit 10.54 Consent Letter The undersigned, Ding Wenting, a citizen of the People’s Republic of China (“China” or the “PRC”) with the PRC Identification No.: ###########, is the lawful spouse of Zhou Pengwu, a PRC citizen with the PRC Identification No.: ###########. I hereby unconditionally and irrevocably agree on the execution of the following documen |
|
| October 15, 2019 |
EX-10.48 49 a2239805zex-1048.htm EX-10.48 Exhibit 10.48 Consent Letter The undersigned, Ding Wenting, a citizen of the People’s Republic of China (“China” or the “PRC”) with the PRC Identification No.: #########, is the lawful spouse of Zhou Pengwu, a PRC citizen with the PRC Identification No.: ###########. I hereby unconditionally and irrevocably agree on the execution of the following documents |
|
| October 15, 2019 |
Exhibit 10.46 Equity Interest Pledge Agreement This Equity Interest Pledge Agreement (this ?Agreement?) is entered into by and among the following parties on October 29, 2018 in Shenzhen, the People?s Republic of China (?China? or the ?PRC?): Party A: Shenzhen Pengai Hospital Investment Management Co., Ltd. (the ?Pledgee?), a limited liability company incorporated and existing under the PRC laws, |
|
| October 15, 2019 |
EX-10.37 38 a2239805zex-1037.htm EX-10.37 Exhibit 10.37 Loan Agreement This Loan Agreement (the “Agreement”) is entered into by and between the parties below as of August 10, 2018 in Shenzhen, the People’s Republic of China (“China” or the “PRC”): (1) Shenzhen Pengai Hospital Investment Management Co., Ltd. (the “Lender”), a limited liability company incorporated and existing under the laws of the |
|
| October 15, 2019 |
EX-10.21 22 a2239805zex-1021.htm EX-10.21 Exhibit 10.21 Amended and Restated Exclusive Option Agreement This Amended and Restated Exclusive Option Agreement (this “Agreement”) is executed by and among the following parties as of January 1, 2019 in Shenzhen, the People’s Republic of China (“China” or the “PRC”): Party A: Shenzhen Pengai Hospital Investment Management Co., Ltd., a limited liability |
|
| October 15, 2019 |
EX-10.19 20 a2239805zex-1019.htm EX-10.19 Exhibit 10.19 Amended and Restated Loan Agreement This Amended and Restated Loan Agreement (the “Agreement”) is entered into by and between the parties below as of January 1, 2019 in Shenzhen, the People’s Republic of China (“China” or the “PRC”): (1) Shenzhen Pengai Hospital Investment Management Co., Ltd. (the “Lender”), a limited liability company incor |
|
| October 15, 2019 |
EX-10.16 17 a2239805zex-1016.htm EX-10.16 Exhibit 10.16 Amended and Restated Equity Interest Pledge Agreement This Amended and Restated Equity Interest Pledge Agreement (this “Agreement”) is entered into by and among the following parties on April 1, 2019 in Shenzhen, the People’s Republic of China (“China” or the “PRC”): Party A: Shenzhen Pengai Hospital Investment Management Co., Ltd. (the “Pled |
|
| October 15, 2019 |
Exhibit 10.10 Equity Interest Pledge Agreement This Equity Interest Pledge Agreement (this ?Agreement?) is entered into by and among the following parties on November 5, 2018 in Shenzhen, the People?s Republic of China (?China? or the ?PRC?): Party A: Shenzhen Pengai Hospital Investment Management Co., Ltd. (the ?Pledgee?), a limited liability company incorporated and existing under the PRC laws, |
|
| October 15, 2019 |
Exhibit 10.41 Power of Attorney The undersigned, Zhou Pengwu, a PRC citizen with Identification No.: #########, execute this Power of Attorney on August 10, 2018, which becomes effective as of the date hereof. As of the date of the Power of Attorney, I hold 22% of the equity interests in Shenzhen Pengai Xiuqi Aesthetic Medical Hospital (the ?Company?). For the equity interests in the Company that |
|
| October 15, 2019 |
EX-10.50 51 a2239805zex-1050.htm EX-10.50 Exhibit 10.50 ECONOMIC INTEREST TRANSFER AGREEMENT This Economic Interest Transfer Agreement (the “Agreement”) is entered into by and among the parties below as of January 1, 2019 in Shenzhen, the People’s Republic of China (“China” or the “PRC”): (1) Zhou Pengwu (the “Transferor”), a Chinese citizen with the Identification No.: ############; (2) Shenzhen |
|
| October 15, 2019 |
EX-4.5 5 a2239805zex-45.htm EX-4.5 Exhibit 4.5 CONVERTIBLE NOTE THE NOTE REPRESENTED BY THIS INSTRUMENT AND THE SECURITIES ISSUABLE UPON CONVERSION OF THE NOTE HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION AND MAY NOT BE TRANSFERRED, SOLD OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO AN EFFEC |
|
| October 15, 2019 |
EX-10.7 8 a2239805zex-107.htm EX-10.7 Exhibit 10.7 Loan Agreement This Loan Agreement (the “Agreement”) is entered into by and between the parties below as of November 5, 2018 in Shenzhen, the People’s Republic of China (“China” or the “PRC”): (1) Shenzhen Pengai Hospital Investment Management Co., Ltd. (the “Lender”), a limited liability company incorporated and existing under the laws of the PRC |
|
| October 15, 2019 |
Exhibit 99.6 The board of Directors Aesthetic Medical International Holdings Group Limited 1122 Nanshan Boulevard Nanshan District, Shenzhen Guangdong Province, China 518052 Date: September 30, 2019 Dear Sirs, CONSENT TO ACT AS INDEPENDENT NON-EXECUTIVE DIRECTOR I, the undersigned, hereby consent to act as an independent non-executive director of the Company, effective upon the completion of the C |
